JP2020504597A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020504597A5 JP2020504597A5 JP2019520731A JP2019520731A JP2020504597A5 JP 2020504597 A5 JP2020504597 A5 JP 2020504597A5 JP 2019520731 A JP2019520731 A JP 2019520731A JP 2019520731 A JP2019520731 A JP 2019520731A JP 2020504597 A5 JP2020504597 A5 JP 2020504597A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- alcam
- complex
- monoclonal anti
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201641035602 | 2016-10-18 | ||
| IN201641035602 | 2016-10-18 | ||
| PCT/IB2017/056403 WO2018073721A1 (en) | 2016-10-18 | 2017-10-16 | Use of itolizumab to reduce phosphorylation of cd6 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020504597A JP2020504597A (ja) | 2020-02-13 |
| JP2020504597A5 true JP2020504597A5 (cg-RX-API-DMAC10.html) | 2020-11-26 |
| JP7065085B2 JP7065085B2 (ja) | 2022-05-11 |
Family
ID=62019244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019520731A Expired - Fee Related JP7065085B2 (ja) | 2016-10-18 | 2017-10-16 | Cd6のリン酸化を低減させるためのイトリズマブの使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20190248913A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3528846A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7065085B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR102469798B1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU2017345390B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3076861A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL266087B2 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2018073721A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2993186T (pt) | 2008-03-14 | 2019-11-29 | Biocon Ltd | Anticorpo monoclonal e um método do mesmo |
| US10189899B2 (en) | 2013-07-23 | 2019-01-29 | Biocon Limited | Use of a CD6 binding partner and method based thereon |
| KR102514528B1 (ko) | 2016-10-21 | 2023-03-27 | 바이오콘 리미티드 | 루푸스 치료를 위한 단일클론항체 및 이의 치료방법 |
| WO2019169015A1 (en) * | 2018-02-27 | 2019-09-06 | Equillium, Inc. | Anti cd6 antibodies for treating severe asthma |
| US20230076643A1 (en) * | 2019-12-30 | 2023-03-09 | City Of Hope | Methods of making and using regulatory t cells and effector t cells having chimeric antigen receptors targeted to cd6, cd19, and/or an il-13r for treatment of autoimmune disorders and cancers |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2993186T (pt) * | 2008-03-14 | 2019-11-29 | Biocon Ltd | Anticorpo monoclonal e um método do mesmo |
| US10189899B2 (en) * | 2013-07-23 | 2019-01-29 | Biocon Limited | Use of a CD6 binding partner and method based thereon |
| KR102514528B1 (ko) * | 2016-10-21 | 2023-03-27 | 바이오콘 리미티드 | 루푸스 치료를 위한 단일클론항체 및 이의 치료방법 |
| US20230151107A1 (en) * | 2020-04-04 | 2023-05-18 | Biocon Limited | Anti-cd6 antibody compositions and methods for treating and reducing negative effects of a coronavirus including covid-19 |
-
2017
- 2017-10-16 IL IL266087A patent/IL266087B2/en unknown
- 2017-10-16 EP EP17862860.8A patent/EP3528846A4/en active Pending
- 2017-10-16 CA CA3076861A patent/CA3076861A1/en active Pending
- 2017-10-16 AU AU2017345390A patent/AU2017345390B2/en active Active
- 2017-10-16 KR KR1020197014350A patent/KR102469798B1/ko active Active
- 2017-10-16 JP JP2019520731A patent/JP7065085B2/ja not_active Expired - Fee Related
- 2017-10-16 WO PCT/IB2017/056403 patent/WO2018073721A1/en not_active Ceased
-
2019
- 2019-04-17 US US16/387,442 patent/US20190248913A1/en not_active Abandoned
-
2023
- 2023-06-15 US US18/335,542 patent/US20240101700A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022011935A (es) | Terapeuticos de anticuerpo que se unen a ctla4. | |
| WO2019126514A3 (en) | Antibodies to lilrb2 | |
| EP4371570A3 (en) | Treatment of igg4-related diseases with anti-cd19 antibodies crossbinding to cd32b | |
| HK1218550A1 (zh) | 常見輕鏈小鼠 | |
| MX2017003565A (es) | Anticuerpos anti-edad para el tratamiento de inflamacion y trastornos autoinmunes. | |
| HK1208994A1 (en) | Methods for making fully human bispecific antibodies using a common light chain | |
| WO2016201389A3 (en) | Anti-cd33 antibodies and methods of use thereof | |
| WO2016201388A3 (en) | Anti-cd33 antibodies and methods of use thereof | |
| EA201600354A1 (ru) | Антигенсвязывающая молекула, содержащая вариабельную область антитела | |
| BR112018015480A2 (pt) | proteínas de ligação ao antígeno que se ligam a pd-l1 | |
| EP4545567A3 (en) | Mice expressing a limited immunoglobulin light chain repertoire | |
| PH12021550054A1 (en) | Variants of cd38 antibody and uses thereof | |
| WO2014055897A3 (en) | Human monoclonal anti-pd-l1 antibodies and methods of use | |
| PE20161092A1 (es) | Anticuerpos especificos para el ligando 1a tipo factor de necrosis tumoral y composiciones y uso de ellos | |
| EA033072B1 (ru) | Применение антител к семафорину 4d для лечения болезни хантингтона | |
| CL2007003479A1 (es) | Anticuerpo monoclonal humano anti-cd22 o un fragmento de union a antigeno del mismo; acido nucleico, vector, celula huesped; método de preparacion; composicion; inmunoconjugado; y su uso para inhibir el crecimiento de un tumor o tratar un desorden inflamatorio o autoinmune en un sujeto. | |
| WO2015161311A3 (en) | Humanized anti-tf-antigen antibodies | |
| JP2016183163A5 (cg-RX-API-DMAC10.html) | ||
| WO2019112978A3 (en) | Anti-dclk1 antibodies and chimeric antigen receptors, and compositions and methods of use thereof | |
| EP3768719A4 (en) | HIGH AFFINITY NEUTRALIZING ANTIBODIES AGAINST PROGRAMMED DEATH LIGAND 1 (PD-L1) AND THEIR USE | |
| Ehrhold et al. | Present-day sedimentation rates and evolution since the last maximum flooding surface event in the Bay of Brest (WN France) | |
| Choi et al. | SOME RECURRENCE RELATIONS FOR THE JACOBI POLYNOMIALS P (α, β) n (x) | |
| HK40070609A (en) | Humanized antibodies to tnf-like ligand 1a (tl1a) and uses thereof | |
| Cook | Russia's Fragmented Welfare State | |
| Roperch et al. | Tectonic Evolution of the Patagonian Orocline: New Insights from a Paleomagnetic Study in Southernmost America |